Neoplasm, Plasma Cell
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease (NCT04776330) | Chongqing Precision Biotech Co., Ltd | 2021-03-07 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma (NCT04309084) | Celularity Incorporated | 2020-05-12 |
| Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma (NCT04272151) | Chongqing Precision Biotech Co., Ltd | 2019-12-01 |
| BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease (NCT04271644) | Chongqing Precision Biotech Co., Ltd | 2019-04-01 |
Track Neoplasm, Plasma Cell automatically
Every clearance here is in the API, with alerts when new ones post.